Pacira pharmaceuticals inc stock price

Pacira Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development, commercialization and manufacture of new pharmaceutical products, based on its proprietary DepoFoam drug delivery technology, for use in hospitals and ambulatory … PCRX Stock Quote - Pacira Biosciences, Inc. Stock Price Today PCRX stock quote, chart and news. Get Pacira Biosciences, Inc.'s stock price today.

PCRX Stock Quote - Pacira BioSciences, Inc. Common Stock ... Mar 27, 2020 · Pacira BioSciences, Inc. is the holding company for our California operating subsidiary named Pacira Pharmaceuticals, Inc., or Pacira California. In March 2007, we acquired Pacira California from SkyePharma Holdings, Inc. (now a subsidiary of Vectura Group plc), or Skyepharma (referred to herein as the "Skyepharma Acquisition"). PCRX - Pacira Pharm Stock Price - Barchart.com Pacira Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development, commercialization and manufacture of new pharmaceutical products, based on its proprietary DepoFoam drug delivery technology, for use in hospitals and ambulatory … PCRX Stock Quote - Pacira Biosciences, Inc. Stock Price Today PCRX stock quote, chart and news. Get Pacira Biosciences, Inc.'s stock price today.

Pacira BioSciences, Inc. (PCRX) Stock Analysis & News ...

investment & stock information. Get the latest Pacira Pharmaceuticals, Inc. PCRX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. View PCRX's stock price, price target, earnings, financials, forecast, insider trades, The company was formerly known as Pacira Pharmaceuticals, Inc. and   The firm engages in the development, commercialization and manufacture of pharmaceutical products for use in postsurgical outcomes for acute care practitioners  Pacira Pharmaceuticals Inc. (PCRX) Stock Quote and detailed dividend history including dividend dates, yield, company news, and key financial metrics.

Pacira BioSciences, Inc. (PCRX) Stock Historical Prices ...

Pacira Biosciences, Inc. operates as a holding company, which engages in the development, commercialization, and manufacture of pharmaceutical products  Real time Pacira BioSciences (PCRX) stock price quote, stock graph, news & analysis. Pacira Pharmaceuticals Inc (PCRX) Q3 2019 Earnings Call Transcript . Pacira BioSciences, Inc. Common Stock (PCRX) Stock Quotes - Nasdaq offers a Delaware corporation, changed its name from Pacira Pharmaceuticals, Inc. About Pacira BioSciences Inc. Pacira Biosciences, Inc. operates as a pharmaceutical company. The Company offers non-opioid pain management and  investment & stock information. Get the latest Pacira Pharmaceuticals, Inc. PCRX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

PCRX: Get the latest Pacira Pharmaceuticals stock price and detailed information including PCRX news, historical charts and realtime prices.

Pacira BioSciences Inc., PCRX Quick Chart - (NAS) PCRX ... Pacira BioSciences started at buy with $60 stock price target at SunTrust RH MarketWatch. Friday, March 08, 2019. 07:36 AM ET. Pacira Pharmaceuticals reiterated as sell at Stifel MarketWatch. Tuesday, March 05, 2019. 09:00 AM ET. Pacira stock down 1.9% after company announces MyoScience acquisition MarketWatch.

Mar 11, 2013 · Pacira Pharmaceuticals Inc. Stock Upgraded (PCRX) largely solid financial position with reasonable debt levels by most measures and solid stock price performance. Pacira Pharmaceuticals

Feb 21, 2020 · Pacira BioSciences, Inc. PCRX reported fourth-quarter 2019 earnings of 56 cents per share, surpassing the Zacks Consensus Estimate of 44 cents and increasing from the year-ago figure of … Pacira Biosciences, Inc. - TheStreet Pacira Pharmaceuticals (PCRX) Stock Price Target Cut at Jefferies. By Kaya Yurieff. Feb 26, 2016 9:43 AM EST. MARKETS. Pacira Pharmaceuticals (PCRX) Stock Slumps Following Q4 Results. PCRX | Pacira BioSciences Inc. Stock Price & News - WSJ

PCRX -- Is Its Stock Price A Worthy Investment? Learn More. PCRX's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 287.6 -- higher than 89.72% of US-listed equities with positive expected earnings growth. The price/operating cash flow metric for Pacira BioSciences Inc is higher than 83.33% of stocks in our set with a positive cash flow. Pacira Pharmaceuticals | Crunchbase Pacira Pharmaceuticals Inc. was formerly known as DepoTech Corp. was formerly as SkyePharma Inc. and changed its name to Pacira Pharmaceuticals Inc. in June, 2007. The company was founded in 1989 and is based in San Diego, California. Pacira Pharmaceuticals Inc. operates as a subsidiary of Pacira, Inc. Pacira Pharmaceuticals Inc. Stock Upgraded (PCRX) - TheStreet